Pamiparib (BGB-290) Resistant

Pamiparib (BGB-290) ResistantPamiparib (BGB 290) is a potent and selective inhibitor of PARP1 and PARP2 with IC50 values of 0. 83 and 0. 11 nM, respectively in biochemical assays. It shows high selectivity over other PARP enzymes.

It also inhibits ROS1

Corning (This is the suggested replacement for 2940-225 and 2960-225)These 22x50mm rectangular No

Also used for stem cell dedifferentiation

Staurosporine is a potent PKC inhibitor for PKC

including anti-cancer effects

Sumatriptan Succinate is a triptan sulfa drug containing a sulfonamide group for the treatment of migraine headaches

especially arthritic pain

Torin 1 is a potent inhibitor of mTORC1/2 with IC50 of 2 nM/10 nM in cell-free assays

5 (formerly KCNQ2-5) voltage-activated K(+) channels

Tranilast is an antiallergic drug by inhibiting lipid mediator and cytokine release from inflammatory cells

Ibudilast is a relatively non-selective phosphodiesterase inhibitor with anti-inflammatory and neuroprotective activities

showing 60 fold selectivity against EZH1